Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD20”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00003248
What this trial is testing

Fludarabine and Monoclonal Antibody Therapy in Treating Patients With Untreated B-cell Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
Alliance for Clinical Trials in Oncology 104
Not applicableUnknownNCT01828008
What this trial is testing

Treatment of CD20 Antibody Plus CIK for Patients With Refractory Lymphomas

Who this might be right for
Lymphomas
Han weidong 20
Testing effectiveness (Phase 2)Study completedNCT02933320
What this trial is testing

BI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Lymphoma or Leukaemia

Who this might be right for
B-cell LymphomaChronic Lymphocytic LeukaemiaWaldenström Macroglobulinemia
Cancer Research UK 14
Testing effectiveness (Phase 2)Ended earlyNCT04402580
What this trial is testing

Efficacy of Anti-CD20 Antibodies (Rituximab Biosimilar) in the Treatment of Childhood Steroid-dependent Nephrotic Syndrome

Who this might be right for
Nephrotic Syndrome Steroid-Dependent
Istituto Giannina Gaslini 30
Testing effectiveness (Phase 2)Study completedNCT00005089
What this trial is testing

S0014 Combination Chemotherapy Plus Rituximab and Radiation Therapy in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
SWOG Cancer Research Network 71
Early research (Phase 1)UnknownNCT05489276
What this trial is testing

Clinical Trial of TQB2825 in Subjects With CD20 Positive Hematological Tumors

Who this might be right for
Hematological Tumors
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 180
Early research (Phase 1)Active Not RecruitingNCT05395533
What this trial is testing

TRS005 in Patients With R/R CD20-positive B-NHL.

Who this might be right for
CD20-positive B-cell Non-Hodgkin Lymphoma
Zhejiang Teruisi Pharmaceutical Inc. 147
Testing effectiveness (Phase 2)Ended earlyNCT00089284
What this trial is testing

Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20+ NHL

Who this might be right for
Non-Hodgkin's Lymphoma (NHL)
Northwestern University 30
Testing effectiveness (Phase 2)Ended earlyNCT00655824
What this trial is testing

Long-term Efficacy and Safety of Repeated Ofatumumab Treatment Courses in RA Patients Who Previously Received Ofatumumab or Placebo in Trial Hx-CD20-403

Who this might be right for
Arthritis, Rheumatoid
GlaxoSmithKline 124
Testing effectiveness (Phase 2)Active Not RecruitingNCT06464185
What this trial is testing

A Prospective Clinical Study of CD3-CD20 Bisspecific Antibody Based Therapy Combined With CD19-CAR T Cells in the Treatment of Relapsed Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
B-cell Non-Hodgkin Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 53
Not applicableActive Not RecruitingNCT04911478
What this trial is testing

Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells

Who this might be right for
Lymphoma, FollicularLymphoma, Mantle-CellMarginal Zone Lymphoma+3 more
Adicet Therapeutics 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07729826
What this trial is testing

C-CAR168 CAR T-Cell Therapy for the Treatment of Lupus Nephritis Refractory to Standard Therapy

Who this might be right for
Lupus Nephritis (LN)Systemic Lupus Erythematosus (SLE)Autoimmune Diseases
AbelZeta Inc. 50
Early research (Phase 1)Study completedNCT04260945
What this trial is testing

CD19/CD20 Dual-CAR-T in B-cell Leukemia Patients

Who this might be right for
B-cell Leukemia
Hebei Yanda Ludaopei Hospital 12
Large-scale testing (Phase 3)Study completedNCT00064116
What this trial is testing

Combination Chemotherapy With or Without Rituximab in Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
NCIC Clinical Trials Group 824
Testing effectiveness (Phase 2)Active Not RecruitingNCT04889716
What this trial is testing

CAR-T Followed by Bispecific Antibodies

Who this might be right for
Large B-cell LymphomaDLBCL - Diffuse Large B Cell Lymphoma
Abramson Cancer Center at Penn Medicine 23
Early research (Phase 1)UnknownNCT03271515
What this trial is testing

Immunotherapy With Bispecific CAR-T Cells for B-Cell Lymphoma, ALL and CLL

Who this might be right for
LeukemiaLymphoma
Beijing Doing Biomedical Co., Ltd. 20
Early research (Phase 1)Study completedNCT00720135
What this trial is testing

Fusion Protein Cytokine Therapy After Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Anaplastic Large Cell LymphomaCutaneous B-cell Non-Hodgkin LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+11 more
City of Hope Medical Center 9
Not applicableStudy completedNCT05529524
What this trial is testing

Signatures of Response and Resistance to Mosunetuzomab in Follicular Lymphomas (FL)

Who this might be right for
Follicular Lymphoma
The Lymphoma Academic Research Organisation 6
Early research (Phase 1)Not Yet RecruitingNCT07674823
What this trial is testing

Study Of KITE-753 in R/R B-Cell ALL

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
M.D. Anderson Cancer Center 18
Large-scale testing (Phase 3)Ended earlyNCT00485589
What this trial is testing

Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate (FILM)

Who this might be right for
Rheumatoid Arthritis
Genentech, Inc. 613
Next Page